ProMIS Neurosciences Inc. (NASDAQ: PMN)
$2.16
-0.0392 ( -1.78% ) 4.5K
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Market Data
Open
$2.16
Previous close
$2.20
Volume
4.5K
Market cap
$41.52M
Day range
$2.14 - $2.20
52 week range
$0.95 - $8.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Aug 25, 2023 |
8-k | 8K-related | 18 | Aug 22, 2023 |
8-k | 8K-related | 15 | Aug 14, 2023 |
10-q | Quarterly Reports | 62 | Aug 14, 2023 |
8-k | 8K-related | 21 | Jul 14, 2023 |
8-k | 8K-related | 15 | Jul 10, 2023 |